Subcutaneous epoetin beta in renal anemia : An open multicenter dose titration study of patients on continuous peritoneal dialysis
Objective: To establish dose requirements (target hemoglobin > 100 g/L) and safety of subcutaneously administered epoetin beta. Design: Open multicenter study. Patients: Forty-five anemic patients (21 female, 24 male; mean age 55 years; range 20-79 years) who had been on continuous peritoneal dialysis for 1-157 months (mean 24 months). Thirty patients required blood transfusions during the year pr